View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Philips provides update on the Annual General Meeting of Shareholders ...

Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda April 25, 2025 Amsterdam, the Netherlands –  (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM agenda includes the proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025, given his extensive expertise and experience in health technology and quality. Since the company published the agenda for the AGM, Mr White has been nominated to be...

Bruno Cavalier ... (+2)
  • Bruno Cavalier
  • Luis de Toledo Heras
Bruno Cavalier ... (+2)
  • Bruno Cavalier
  • Luis de Toledo Heras
Luis de Toledo Heras
  • Luis de Toledo Heras
 PRESS RELEASE

Philips demonstrates innovation power, topping European Patent Office ...

Philips demonstrates innovation power, topping European Patent Office Medtech filings in 2024 March 25, 2025 Amsterdam, the Netherlands –  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that in 2024 it was the leading applicant in the field of medical technology at the (EPO), filing 594 Medtech patent applications. This achievement underscores the company's ongoing dedication to transforming healthcare delivery by integrating informatics and AI to improve workflows, enhance the quality of care, and lower costs of care per patient.The innovations by Philips, ...

 PRESS RELEASE

Philips and Ibex expand partnership to enhance AI-enabled pathology wo...

Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care March 24, 2025 Interoperable AI-powered digital pathology workflows support confident cancer diagnosis Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new release of Philips IntelliSite Pathology Solution (PIPS) to further accelerate the adoption of AI-enabled digital pathology to address the pressure pathologists face because of the global shortage of pat...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2025

Philips convenes the Annual General Meeting of Shareholders 2025 March 24, 2025Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes: Proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025.Proposals to re-appoint Ms Indra Nooyi (American, 1955) and Ms Chua Sock Koong (Singaporean, 1957) as members of the Supervisory Board, with effect from May 8, 202...

 PRESS RELEASE

Philips highest ranked medical technology company among Clarivate Top ...

Philips highest ranked medical technology company among Clarivate Top 100 Global Innovators March 12, 2025Amsterdam, the Netherlands –  (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the , reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, Philips has been included in this major assessment of global innovators for 12 consecutive years. Roy Jakobs, CEO of Royal Philips said: "At Philips, we’ve been innovating for over 130 years to i...

Luis Arredondo
  • Luis Arredondo

ACS: 4Q’24 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'24 vs. 4Q'23 Results Sales: € 11.931 Bn (+27.7% vs. +17.7% BS(e) and +18.2% consensus); EBITDA: € 777.0 M (+60.5% vs. +45.2% BS(e) and +47.5% consensus); EBIT: € 511.0 M (+44.4% vs. +27.9% BS(e) and +21.5% consensus); Net Profit: € 223.0 M (+9.3% vs. -10.9% BS(e) and -2.5% consensus); FY2024 vs. FY2023 Results Sales: € 41.633 Bn (+16.5% vs. +13.9% BS(e) and +14.0% consensus); EBITDA: € 2.456 Bn (+28.7% vs. +24.8% BS(e) and +25.4% consensus); EBIT: € 1.59 Bn (+19.9% vs. +15.5% BS(e) and +13.8%...

Luis Arredondo
  • Luis Arredondo
Ignacio Romero
  • Ignacio Romero

VIDRALA: FY2024 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'24 vs. 4Q'23 Results Sales: € 371.9 M (+2.0% vs. +4.2% BS(e)); EBITDA: € 116.3 M (+48.9% vs. +42.0% BS(e)); FY2024 vs. FY2023 Results Sales: € 1.588 Bn (+1.9% vs. +2.4% BS(e)); EBITDA: € 454.0 M (+15.3% vs. +13.9% BS(e)); Net Profit: € 298.3 M (+27.8% vs. +19.2% BS(e));

Ignacio Romero
  • Ignacio Romero

VIDRALA: RDOS. 2024 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'24 vs 4T'23: Ventas: 371,9 M euros (+2,0% vs +4,2% BS(e) y n/a consenso); EBITDA: 116,3 M euros (+48,9% vs +42,0% BS(e) y n/a consenso); Rdos. 2024 vs 2023: Ventas: 1.588 M euros (+1,9% vs +2,4% BS(e)); EBITDA: 454 M euros (+15,3% vs +13,9% BS(e)); BDI: 298 M euros (+27,8% vs +19,2% BS(e)).

Luis de Toledo Heras
  • Luis de Toledo Heras
Luis Arredondo
  • Luis Arredondo

ACS: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'24 vs 4T'23: Ventas: 11.931 M euros (+27,7% vs +17,7% BS(e) y +18,2% consenso); EBITDA: 777,0 M euros (+60,5% vs +45,2% BS(e) y +47,5% consenso); EBIT: 511,0 M euros (+44,4% vs +27,9% BS(e) y +21,5% consenso); BDI: 223,0 M euros (+9,3% vs -10,9% BS(e) y -2,5% consenso). Rdos. 2024 vs 2023: Ventas: 41.633 M euros (+16,5% vs +13,9% BS(e) y +14,0% consenso); EBITDA: 2.456 M euros (+28,7% vs +24,8% BS(e) y +25,4% consenso); EBIT: 1.590 M euros (+19,9% vs +15,5% BS(e) y +13,8% consenso); BDI...

Research Department
  • Research Department

IBERIAN DAILY 28 FEBRUARY + 4Q'24 RESULTS. PREVIEWS (ANÁLISIS BANCO SA...

NEWS SUMMARY: ACERINOX, ACCIONA, ACCIONA ENERGÍA, ACS, AMADEUS, COLONIAL, ENCE, FERROVIAL, GRIFOLS, MELIÁ HOTELES, MERLIN PROPERTIES, PUIG BRANDS, REPSOL, SACYR, VISCOFAN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’24 results to be released over the coming days in Spain. Losses in Europe Despite many companies releasing their 4Q’24 results yesterday, the session was mar...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch